Myocardial Lipidomics Revealed Glycerophospholipid and Sphingolipid Metabolism as Therapeutic Targets of Qifu Decoction Against Heart Failure

Documenti analoghi

• Multimodal Metabolomics Analysis Reveals That Classic Decoction Mitigates Myocardial Ischemia‐Induced Damage by Modulating Energy and Branched‐Chain Amino Acid Metabolism
  di: Zhimin Ying, et al.
  Pubblicazione: (2025)
• A Cooperative Strategy of Hippocampus Lipidomics and Anti‐Inflammatory Analysis to Evaluate the Antidepressant Effect of Zhi‐Zi‐Chi Decoction on CUMS Mice
  di: Chuan Chai, et al.
  Pubblicazione: (2025)
• Metabolic Profile In Vivo and Potential Mechanisms of Danggui Jianzhong Decoction Against Gastric Ulcer by Ultra‐High‐Performance Quadrupole Time‐of‐Flight Mass Spectrometry Combined With Network Pharmacology Analysis
  di: Tian‐hua Duan, et al.
  Pubblicazione: (2025)
• Effects of Long‐Term Administration and Multicomponent Formulation on the Disposition of Calycosin From Danggui Buxue Decoction: A Pharmacokinetic, Tissue Distribution, and Metabolism Study
  di: Chunxiao Chen, et al.
  Pubblicazione: (2026)
• Therapeutic potential of Shaoyao Gancao Decoction in mitigating anti‐tuberculosis drug‐induced liver injury through Nrf‐2/HO‐1/NF‐κB signaling
  di: Huan Zhang, et al.
  Pubblicazione: (2024)